RNABLE LTD

General Data

Reg Number
516421203
Sector
Biomed
Established
2021
No. of Employees
6
Stage
R&D
Additional Funding
0

Technology

RNA transcripts undergo modifications that are recognized by specific RNA binding proteins dictating their stability. Prof. Rotem Karni, RNAble inventor, discovered that targeting components of the RNA epitranscriptomic machinery with small molecules resulted in stabilization of several RNAs, including unstable nonsense mutated transcripts which are degraded by the nonsense mediated decay machinery (NMD). This opens the possibility to restore the expression of mutated genes essential in rare diseases and to suppress the growth of specific cancers. INDICATIONS

Targeted Customers

Pharmaceutical companies

Contact information

Name
Country
Israel
Zip
7403635

Tags

BiotechnologyCancerLife SciencesMedTechRNARNA TherapeuticsTherapeutics

Classified Technologies

Biomedicine and pharmaceuticals

Winning details

Route name
Winning year

Designated biotechnology incubators
Designated biotechnology incubators
2024